Topic: Hormonal Therapy

Disease Flare with LHRH Agonists is a Myth

Abraham Morgentaler, MD, FACS, describes the phenomenon of testosterone flare following prostate cancer treatment with luteinizing hormone-releasing hormone (LHRH) agonists and argues that this flare does not necessarily cause disease progression. He also discusses the effects of testosterone therapy in patients with untreated prostate cancer.

Read More

Join the GRU Community

- Why Join? -